mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern RR Goel, MM Painter, SA Apostolidis, D Mathew, W Meng, AM Rosenfeld, ... Science 374 (6572), abm0829, 2021 | 754 | 2021 |
An NK-like CAR T cell transition in CAR T cell dysfunction CR Good, MA Aznar, S Kuramitsu, P Samareh, S Agarwal, G Donahue, ... Cell 184 (25), 6081-6100. e26, 2021 | 222 | 2021 |
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19 LA Vella, JR Giles, AE Baxter, DA Oldridge, C Diorio, L Kuri-Cervantes, ... Science immunology 6 (57), eabf7570, 2021 | 208 | 2021 |
Next-generation CAR T-cell therapies RM Young, NW Engel, U Uslu, N Wellhausen, CH June Cancer discovery 12 (7), 1625-1633, 2022 | 89 | 2022 |
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy N Wellhausen, RP O’Connell, S Lesch, NW Engel, AK Rennels, ... Science translational medicine 15 (714), eadi1145, 2023 | 35 | 2023 |
Pathogenesis, symptomatology, and transmission of SARS-CoV-2 through analysis of viral genomics and structure HM Rando, AL MacLean, AJ Lee, R Lordan, S Ray, V Bansal, AN Skelly, ... MSystems 6 (5), 10.1128/msystems. 00095-21, 2021 | 35 | 2021 |
Identification and development of therapeutics for COVID-19 HM Rando, N Wellhausen, S Ghosh, AJ Lee, AA Dattoli, F Hu, JB Byrd, ... Msystems 6 (6), e00233-21, 2021 | 20 | 2021 |
Production of human Crispr-engineered Car-T cells S Agarwal, N Wellhausen, BL Levine, CH June JoVE (Journal of Visualized Experiments), e62299, 2021 | 17 | 2021 |
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy N Wellhausen, S Agarwal, PC Rommel, SI Gill, CH June Current opinion in immunology 74, 76-84, 2022 | 16 | 2022 |
SARS-CoV-2 and COVID-19: An evolving review of diagnostics and therapeutics HM Rando, CS Greene, MP Robson, SM Boca, N Wellhausen, R Lordan, ... Manubot, 2021 | 12 | 2021 |
Application of traditional vaccine development strategies to SARS-CoV-2 HM Rando, R Lordan, AJ Lee, A Naik, N Wellhausen, E Sell, L Kolla, ... Msystems 8 (2), e00927-22, 2023 | 10 | 2023 |
Epitope editing in hematopoietic cells enables CD45-directed immune therapy N Wellhausen, AK Rennels, S Lesch, S Agarwal, B Charria, G Choi, ... Blood 140 (Supplement 1), 862-864, 2022 | 8 | 2022 |
Combination therapy for solid tumors: taking a classic CAR on new adventures O Dagher, TR King, N Wellhausen, AD Posey Cancer Cell 38 (5), 621-623, 2020 | 8 | 2020 |
Nextgeneration CAR T-cell therapies. Cancer Discov 2022; 12: 1625–1633. doi: 10.1158/2159-8290 RM Young, NW Engel, U Uslu, N Wellhausen, CH June CD-21-1683, 0 | 8 | |
The coming of age of nucleic acid vaccines during COVID-19 HM Rando, R Lordan, L Kolla, E Sell, AJ Lee, N Wellhausen, A Naik, ... Msystems 8 (2), e00928-22, 2023 | 7 | 2023 |
Pathogenesis, symptomatology, and transmission of SARS-CoV-2 through analysis of viral genomics and structure. mSystems 6: e00095-21 HM Rando, AL MacLean, AJ Lee, R Lordan, S Ray, V Bansal, AN Skelly, ... | 6 | 2021 |
Induction of a CD8 T cell intrinsic DNA damage and repair response is associated with clinical response to PD-1 blockade in uterine cancer Y Muroyama, S Manne, N Wellhausen, DA Oldridge, AR Greenplate, ... bioRxiv, 2022.04. 16.488552, 2022 | 4 | 2022 |
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α C Roselle, I Horikawa, L Chen, AR Kelly, D Gonzales, T Da, ... Proceedings of the National Academy of Sciences 121 (10), e2317735121, 2024 | 2 | 2024 |
Identification of core techniques that enhance genome editing of human T cells expressing synthetic antigen receptors JF Chang, N Wellhausen, NW Engel, JH Landmann, CR Hopkins, ... Cancer Immunology Research, OF1-OF11, 2024 | 1 | 2024 |
Induction of T cell dysfunction and NK-like T cell differentiation in vitro and in patients after CAR T cell treatment CR Good, S Kuramitsu, P Samareh, G Donahue, K Ishiyama, Y Ma, ... Cancer Research 81 (13_Supplement), 60-60, 2021 | 1 | 2021 |